UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
US7700285B1
(en)
|
2005-12-29 |
2010-04-20 |
Boehringer Ingelheim Vetmedica, Inc. |
PCV2 immunogenic compositions and methods of producing such compositions
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
ES2425228T3
(es)
*
|
2005-09-09 |
2013-10-14 |
Intervet International B.V. |
Vacuna contra el PCV-2
|
DK2368572T3
(da)
|
2005-11-04 |
2020-05-25 |
Seqirus Uk Ltd |
Adjuvansvacciner med ikke-virionantigener fremstillet fra influenza-virusser dyrket i cellekultur
|
JP2009514850A
(ja)
|
2005-11-04 |
2009-04-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
アジュバントとして減少した量の水中油型エマルションを有するインフルエンザワクチン
|
NZ567979A
(en)
|
2005-11-04 |
2012-02-24 |
Novartis Vaccines & Diagnostic |
Adjuvanted influenza vaccines including a cytokine-inducing agents which is an agonist of Toll-Like Receptor 7
|
BRPI0620859A2
(pt)
*
|
2005-12-29 |
2011-11-22 |
Boehringer Ingelheim Vetmedica, Inc. |
vacina de combinação multivalente contra pcv2
|
JP5739602B2
(ja)
*
|
2005-12-29 |
2015-06-24 |
ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド |
ブタの臨床症状の緩和のためのpcv2免疫原性組成物の使用
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
EP1991262A4
(en)
*
|
2006-03-03 |
2009-11-04 |
Merial Ltd |
MYCOPLASMA HYOPNEUMONIAE VACCINE
|
US20100068223A1
(en)
|
2006-03-24 |
2010-03-18 |
Hanno Scheffczik |
Storage of Influenza Vaccines Without Refrigeration
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
MX2009002408A
(es)
|
2006-09-11 |
2009-03-20 |
Novartis Ag |
Elaboracion de vacunas para el virus de la influenza sin utilizar huevos.
|
EP2099927A4
(en)
*
|
2006-11-22 |
2010-05-05 |
Boehringer Ingelheim Vetmed |
METHODS FOR REDUCING FLAMBEES OF DISEASES ASSOCIATED WITH PORCINIC CIRCOVIRUS
|
NZ577405A
(en)
|
2006-12-06 |
2012-08-31 |
Novartis Ag |
Vaccines including antigen from four strains of influenza virus
|
EP2859900A1
(en)
*
|
2006-12-11 |
2015-04-15 |
Boehringer Ingelheim Vetmedica, Inc. |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
HUE033130T2
(en)
*
|
2006-12-15 |
2017-11-28 |
Boehringer Ingelheim Vetmedica Inc |
Treatment of seropositive pigs with anti-PCV2 antibody with PCV2 antigen
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
EP1958644A1
(en)
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
CA2720570C
(en)
|
2007-04-06 |
2022-10-04 |
Inviragen, Inc. |
Methods and compositions for live, attenuated dengue viruses
|
KR20100045437A
(ko)
|
2007-06-27 |
2010-05-03 |
노파르티스 아게 |
첨가물이 적은 인플루엔자 백신
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US7829274B2
(en)
*
|
2007-09-04 |
2010-11-09 |
Boehringer Ingelheim Vetmedica, Inc. |
Reduction of concomitant infections in pigs by the use of PCV2 antigen
|
DK2200642T3
(da)
|
2007-10-19 |
2012-07-16 |
Novartis Ag |
Meningococvaccinepræparater
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
LT2224951T
(lt)
*
|
2007-12-21 |
2020-01-10 |
Zoetis Services Llc |
Termiškai apdoroti bakterinai ir iš tokių termiškai apdorotų bakterinų paruoštos emulsinės vakcinos
|
BRPI0821456A2
(pt)
*
|
2007-12-31 |
2015-06-16 |
Boehring Ingelheim Vetmedica Inc |
Partícula similar à pcv2 orf2 com inserção de aminoácido estranho
|
BRPI0907438A2
(pt)
*
|
2008-01-23 |
2015-08-04 |
Boehringer Ingelheim Vetmed |
Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
|
KR20100135766A
(ko)
|
2008-03-18 |
2010-12-27 |
노파르티스 아게 |
인플루엔자 바이러스 백신 항원 제조의 개선
|
US9642908B2
(en)
*
|
2008-07-30 |
2017-05-09 |
University Of Kentucky Research Foundation |
Equine disease model for herpesvirus neurologic disease and uses thereof
|
NZ591768A
(en)
|
2008-09-18 |
2012-11-30 |
Novartis Ag |
Vaccine adjuvant combinations
|
EP3168307B1
(en)
|
2008-11-28 |
2020-07-15 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant avian influenza vaccine and uses thereof
|
JP5642712B2
(ja)
|
2009-02-10 |
2014-12-17 |
ノバルティス アーゲー |
少ない量のスクアレンを含むインフルエンザワクチン
|
US20120093860A1
(en)
|
2009-02-10 |
2012-04-19 |
Novartis Ag |
Influenza vaccines with increased amounts of h3 antigen
|
AU2010212547B2
(en)
|
2009-02-10 |
2015-03-12 |
Seqirus UK Limited |
Influenza vaccine regimens for pandemic-associated strains
|
EP2403526B1
(en)
|
2009-03-06 |
2019-05-15 |
GlaxoSmithKline Biologicals SA |
Chlamydia antigens
|
EP2228054A1
(en)
*
|
2009-03-13 |
2010-09-15 |
ITALFARMACO S.p.A. |
Riluzole aqueous suspensions
|
AU2010227220B2
(en)
|
2009-03-24 |
2014-11-13 |
Glaxosmithkline Biologicals S.A. |
Combinations of meningococcal factor H binding protein and pneumococcal saccharide conjugates
|
CA3154626A1
(en)
|
2009-04-14 |
2010-10-21 |
Glaxosmithkline Biologicals S.A. |
Compositions for immunising against staphylococcus aureus
|
BRPI1010679B1
(pt)
*
|
2009-05-19 |
2020-09-24 |
Bioproperties Pty Ltd |
Cepa de vacina de mycoplasma hyopneumoniae sensível à temperatura e aplicações da mesma, composiçao de vacina, método de preparaçao e uso da mesma
|
KR101800245B1
(ko)
|
2009-05-21 |
2017-11-22 |
노파르티스 아게 |
비-내인성 pol i 프로모터를 사용하는 역 유전학
|
JP5823379B2
(ja)
|
2009-05-29 |
2015-11-25 |
ノバルティス アーゲー |
インフルエンザウイルスヘマグルチニンについてのアッセイ
|
CA2767536A1
(en)
|
2009-07-07 |
2011-01-13 |
Novartis Ag |
Conserved escherichia coli immunogens
|
JP2012532626A
(ja)
|
2009-07-16 |
2012-12-20 |
ノバルティス アーゲー |
無毒化されたEscherichiacoli免疫原
|
EP2459708B1
(en)
*
|
2009-07-31 |
2016-06-22 |
National Research Council of Canada |
H. pylori lipopolysaccharide outer core epitope
|
TWI627281B
(zh)
*
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
KR20120081587A
(ko)
|
2009-09-10 |
2012-07-19 |
노파르티스 아게 |
기도 질병에 대한 조합 백신
|
HUE030664T2
(en)
*
|
2009-09-10 |
2017-05-29 |
Merial Inc |
New vaccine formulations containing saponin-containing adjuvant
|
GB0917003D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Purification of bacterial vesicles
|
GB0917002D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Improved shigella blebs
|
WO2011039631A2
(en)
|
2009-09-30 |
2011-04-07 |
Novartis Ag |
Expression of meningococcal fhbp polypeptides
|
ES2454815T3
(es)
|
2009-10-20 |
2014-04-11 |
Novartis Ag |
Métodos mejorados de genética inversa para la recuperación de virus
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
US9173954B2
(en)
|
2009-12-30 |
2015-11-03 |
Glaxosmithkline Biologicals Sa |
Polysaccharide immunogens conjugated to E. coli carrier proteins
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
MX2012010609A
(es)
|
2010-03-18 |
2012-10-03 |
Novartis Ag |
Vacunas adyuvadas para meningococos serogrupo b.
|
FR2957933B1
(fr)
*
|
2010-03-24 |
2012-04-27 |
Seppic Sa |
Vaccin vivant pour maladies aviaires
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
BR112012025364A2
(pt)
|
2010-04-07 |
2015-09-22 |
Novartis Ag |
método para geração de partícula semelhante a vírus de parvovírus b19
|
JP5815676B2
(ja)
|
2010-04-30 |
2015-11-17 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
H5n1系列に対する汎用ワクチン
|
EP2569007B1
(en)
|
2010-05-11 |
2015-10-14 |
Intervet International B.V. |
Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
|
AU2011254204B2
(en)
|
2010-05-21 |
2015-08-20 |
Seqirus UK Limited |
Influenza virus reassortment method
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
EP2585106A1
(en)
|
2010-06-25 |
2013-05-01 |
Novartis AG |
Combinations of meningococcal factor h binding proteins
|
JP2013533745A
(ja)
|
2010-07-06 |
2013-08-29 |
ノバルティス アーゲー |
ノロウイルスに由来する免疫原性組成物および方法
|
GB201017519D0
(en)
|
2010-10-15 |
2010-12-01 |
Novartis Vaccines Inst For Global Health S R L |
Vaccines
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
ES2681698T3
(es)
|
2011-03-02 |
2018-09-14 |
Glaxosmithkline Biologicals Sa |
Vacunas de combinación con menores dosis de antígeno y/o adyuvante
|
US10030052B2
(en)
|
2011-07-25 |
2018-07-24 |
Glaxosmithkline Biologicals Sa |
Parvovirus Vp1 unique region polypeptides and compositions thereof
|
CN103917245B
(zh)
|
2011-09-14 |
2017-06-06 |
葛兰素史密丝克莱恩生物有限公司 |
用于制备糖‑蛋白质糖缀合物的方法
|
WO2013057715A1
(en)
|
2011-10-20 |
2013-04-25 |
Novartis Ag |
Adjuvanted influenza b virus vaccines for pediatric priming
|
EP2791680B1
(en)
|
2011-12-12 |
2015-12-09 |
Novartis AG |
Assay for influenza virus hemagglutinins
|
JP2015500864A
(ja)
|
2011-12-23 |
2015-01-08 |
ノバルティス アーゲー |
黄色ブドウ球菌(Staphylococcusaureus)に対して免疫するための安定な組成物
|
SI2814508T1
(sl)
*
|
2012-02-14 |
2017-10-30 |
Merial, Inc. |
Rotavirusna podenotska cepiva ter postopki njihove izdelave in uporaba
|
CA2813723A1
(en)
|
2012-03-02 |
2013-09-02 |
Novartis Ag |
Influenza virus reassortment
|
CA2875752A1
(en)
|
2012-06-04 |
2013-12-12 |
Novartis Ag |
Improved safety testing
|
CN104619336A
(zh)
|
2012-08-31 |
2015-05-13 |
诺华股份有限公司 |
用于针对金黄色葡萄球菌的免疫的稳定化的蛋白质
|
WO2014033191A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Stabilised proteins for immunising against staphylococcus aureus
|
WO2014039978A2
(en)
|
2012-09-10 |
2014-03-13 |
Szathmary Dr Susan |
Vaccine to prevent mycoplasmal infection in waterfowl
|
EP2897635A1
(en)
|
2012-09-18 |
2015-07-29 |
Novartis AG |
Outer membrane vesicles
|
MX2015004171A
(es)
|
2012-10-02 |
2015-10-22 |
Glaxosmithkline Biolog Sa |
Conjugados de sacaridos no lineales.
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
WO2014083060A2
(en)
|
2012-11-30 |
2014-06-05 |
Novartis Ag |
Pseudomonas antigens and antigen combinations
|
JP6421128B2
(ja)
|
2012-12-03 |
2018-11-07 |
ノバルティス アーゲー |
リアソータントインフルエンザaウイルス
|
CN105338999B
(zh)
|
2013-03-13 |
2020-02-28 |
诺华股份有限公司 |
乙型流感病毒重配
|
EP2994162B1
(en)
|
2013-05-08 |
2021-04-07 |
Pharmgate Biologics Inc. |
Vaccine for pcv2 and mycoplasma
|
KR20160030097A
(ko)
|
2013-05-10 |
2016-03-16 |
노파르티스 아게 |
인플루엔자 백신에서 기면증 위험의 방지
|
DE202013005100U1
(de)
|
2013-06-05 |
2013-08-26 |
Novartis Ag |
Influenza Virus Reassortierung
|
DE202013005130U1
(de)
|
2013-06-05 |
2013-09-10 |
Novartis Ag |
Influenza Virus Reassortierung
|
BR112015030582A2
(pt)
|
2013-06-06 |
2017-08-29 |
Novartis Ag |
Segmento de hemaglutinina da gripe quimérico e de neuraminidase quimérico, proteína de hemaglutinina quimérica, vírus da gripe rearranjado, métodos para preparação de um vírus da gripe rearranjado e para preparação de uma vacina e sistema de expressão
|
EA035265B1
(ru)
|
2013-10-02 |
2020-05-21 |
Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. |
Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
|
DK3076996T3
(en)
*
|
2013-12-03 |
2020-03-09 |
Intervet Int Bv |
Vaccine mod porcint circovirus type 2
|
CN103751779A
(zh)
*
|
2014-02-25 |
2014-04-30 |
中国农业科学院上海兽医研究所 |
O型口蹄疫多肽的泊洛沙姆凝胶佐剂
|
WO2015144655A1
(en)
|
2014-03-26 |
2015-10-01 |
Glaxosmithkline Biologicals S.A. |
Immunising against staphylococcus aureus
|
WO2015179412A1
(en)
|
2014-05-19 |
2015-11-26 |
Merial, Inc. |
Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (pedv)
|
US20150359880A1
(en)
*
|
2014-06-16 |
2015-12-17 |
Biomune Company |
Dual adjuvant vaccine compositions, preparation and uses
|
CN105288614A
(zh)
*
|
2014-06-18 |
2016-02-03 |
潘皓 |
一种疫苗组合物及其制备方法
|
JP2015120709A
(ja)
*
|
2015-01-09 |
2015-07-02 |
ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex,S.A. De C.V. |
遺伝子組み換え不活性化ウィルスベクターワクチン
|
EP3313439A2
(en)
|
2015-06-26 |
2018-05-02 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
EP3313440A2
(en)
|
2015-06-26 |
2018-05-02 |
Merial, Inc. |
Inactivated canine influenza vaccines and methods of making and uses thereof
|
CA2990745A1
(en)
|
2015-07-07 |
2017-01-12 |
Seqirus UK Limited |
Influenza potency assays
|
MX2018004221A
(es)
|
2015-10-08 |
2019-11-08 |
Pasteur Institut |
Vacuna heterologa atenuada viva para leptospira.
|
MA49414A
(fr)
|
2015-11-23 |
2020-04-22 |
Boehringer Ingelheim Animal Health Usa Inc |
Protéines de fusion de dmdv et e2 et leurs utilisations
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
JOP20190088A1
(ar)
|
2016-10-21 |
2019-04-21 |
Us Agriculture |
نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
|
WO2018099889A1
(en)
*
|
2016-11-29 |
2018-06-07 |
Intervet International B.V. |
Swine vaccine
|
MA49874A
(fr)
|
2016-12-14 |
2020-06-24 |
Boehringer Ingelheim Animal Health Usa Inc |
Vecteurs hvt recombinants exprimant de multiples antigènes de pathogènes aviaires, et vaccins les contenant
|
FR3092754B1
(fr)
*
|
2019-02-18 |
2022-06-03 |
Total Marketing Services |
Composition adjuvante pour vaccin
|
MX2022006005A
(es)
|
2019-11-18 |
2022-10-27 |
Seqirus Pty Ltd |
Metodo para producir virus de la influenza reagrupados.
|
CN113546162B
(zh)
*
|
2021-05-31 |
2023-07-18 |
江苏省农业科学院 |
一种支原体疫苗及其制备方法
|
WO2024133656A1
(en)
|
2022-12-22 |
2024-06-27 |
Ceva Sante Animale |
Oil adjuvant compositions and vaccine emulsions comprising such oil adjuvant compositions
|